Enhancing melanoma therapy with hydrogel microneedles.

النقرات: 125
المعرّف: 281560
2025
مقاييس جودة وأداء المقال
الجودة الإجمالية
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
تقييم الجودة بالذكاء الاصطناعي
لم يتم التحليل
Readership in this journal
Emerging

Ranked #42 of 45 articles by views in Frontiers in oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
الملخص
Melanoma is highly invasive and resistant to conventional treatments, accounting for nearly 75% of skin cancer-related deaths globally. Traditional therapies, such as chemotherapy and immunotherapy, often exhibit limited efficacy and are associated with significant side effects due to systemic drug exposure. Microneedles (MNs), as an emerging drug delivery system, offer multiple advantages, including safety, painlessness, minimal invasiveness, and controlled drug release. Among these, hydrogel microneedles (HMNs) stand out due to their extracellular matrix-like structure and swelling-induced continuous hydrogel channels, which enable the direct delivery of therapeutic agents into the tumor microenvironment (TME). This approach enhances drug bioavailability while reducing systemic toxicity, establishing HMNs as a promising platform for melanoma treatment. This review highlights recent advancements in HMNs for melanoma therapy, focusing on their applications in biomarker extraction for early diagnosis and their role in supporting multimodal treatment strategies, such as chemotherapy, immunotherapy, phototherapy, targeted therapy, and combination therapy. Furthermore, the current matrix materials and fabrication techniques for HMNs are discussed. Finally, the limitations of HMNs in melanoma treatment are critically analyzed, and recommendations for future research and development are provided.
المفتاح المرجعي
zhu2025enhancing استخدم هذا المفتاح للاستشهاد التلقائي في المخطوطة أثناء استخدام مدير المخطوطات أو مدير الأطروحات من SciMatic
المؤلفون Zhu, Lanqi; Qiao, Guanlin; Gao, Huiyang; Jiang, Aowei; Zhang, Linan; Wang, Xiaobing
مجلة Frontiers in oncology
السنة 2025
DOI
10.3389/fonc.2025.1590534
URL
الكلمات المفتاحية
melanoma cancer therapy controlled release drug delivery systems hydrogel microneedles

الاستشهادات

لم يتم العثور على استشهادات. لإضافة استشهاد، تواصل مع المشرف على info@scimatic.org

التعليقات

لا توجد تعليقات بعد. كن أول من يعلق على هذا المقال.